Multicenter Study of the Accuracy of the BD MAX™ MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid
28 September 2019
The BD MAX MDR-TB assay had high sensitivity and specificity for detection of MTB, and RIF and INH drug resistance and may be an important tool for rapid detection of TB and MDR-TB globally.
Further reading: Clinical Infectious Diseases
Author(s): Maunank Shah, Sonia Paradis, Joshua Betz, Natalie Beylis, Renu Bharadwaj, Tatiana Caceres, Eduardo Gotuzzo, Moses Joloba, Vidya Mave, Lydia Nakiyingi, Mark P Nicol, Neeta Pradhan, Bonnie King, Derek Armstrong, Deborah Knecht, Courtney E Maus, Charles K Cooper, Susan E Dorman, Yukari C Manabe
Effective Surveillance Healthy Patients
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
